We explored the signalling pathway related to RBBP5 and found that RBBP5 could affect the progression of melanoma through multiple signalling pathways, including Wnt/β-catenin and epithelial-mesenchymal transition (EMT). The gene discussed is RBBP5; the disease is melanoma.